We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+25.31%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$615M
AUM Growth
-$26.4M
(-4.1%)
Cap. Flow
-$90.4M
Cap. Flow
% of AUM
-14.7%
Top 10 Holdings %
Top 10 Hldgs %
10.02%
Holding
357
New
126
Increased
9
Reduced
90
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$5.42M |
| 2 |
Cabot Corp
CBT
|
+$4.61M |
| 3 |
Brink's
BCO
|
+$4.45M |
| 4 |
FormFactor
FORM
|
+$4.43M |
| 5 |
Badger Meter
BMI
|
+$4.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$5.99M |
| 2 |
Applied Industrial Technologies
AIT
|
+$5.91M |
| 3 |
Nextpower Inc
NXT
|
+$5.79M |
| 4 |
Aaon
AAON
|
+$5.52M |
| 5 |
Leonardo DRS
DRS
|
+$5.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 26.41% |
| 2 | Technology | 22.84% |
| 3 | Healthcare | 18.79% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Financials | 7.29% |
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2024 Portfolio in Review
As of Q2 2024, EAM Investors held 357 positions worth $615M, down 4.1% from $642M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors withdrew a net $90.4M in Q2 2024, closing 116 positions and reducing 90 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.99M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, EAM Investors opened a new position in FTAI Aviation worth $7.04M.
- EAM Investors's largest Q2 2024 buy was FTAI Aviation: 68,171 shares worth $7.04M.
- EAM Investors added most to American Superconductor in Q2 2024, an estimated $2.33M increase.
- EAM Investors's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $5.21M.
- EAM Investors fully exited Viking Therapeutics in Q2 2024, selling an estimated $5.99M.
- EAM Investors's ten largest holdings make up 10% of its $615M portfolio in Q2 2024.
- EAM Investors opened 126 new positions and closed 116 in Q2 2024.
- EAM Investors's portfolio value fell 4.1% quarter-over-quarter to $615M.
Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.